†Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
IMPORTANT SAFETY INFORMATION
Do not use ACTOGAIN in animals intended for breeding. Refer to label for complete directions for use, precautions, and warnings.
Do not use AUREOMYCIN in calves to be processed for veal.
Withdraw AUREO S 700 seven (7) days prior to slaughter. Do not use in calves to be processed for veal.
Do not use BOVATEC in calves to be processed for veal. Do not allow horses or other equines access to feeds containing lasalocid, as ingestion may be fatal. Feeding undiluted or mixing errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep.
Do not allow horses or other equines access to feeds containing CATTLYST. Do not use in animals intended for breeding.
Do not use DECCOX in cows producing milk for food.
Rumensin is a registered trademark of Eli Lilly and Company, its subsidiaries or affiliates. ACT-00058R1
1Animalytix® data, October 2016, Zoetis Services LLC.
2Data on file, Study Report Nos. MC013-06-AULA13, MC014-06-AULA13, MC015-06-AULA13, MC017-06-AULA13, Zoetis Services LLC.
3Reinhardt C. The effects of Cattlyst + Aureomycin vs Rumensin + Tylan in finishing cattle on feedlot performance, carcass traits, and incidence of liver abscesses: a pooled analysis of seven studies, Zoetis Services LLC.
4 Cernicchiaro N, Corbin M, Quinn M, Prouty F, Branine M, Renter DG. Meta-analysis of the effects of laidlomycin propionate, fed alone or in combination with chlortetracycline, compared with monensin sodium, fed alone or in combination with tylosin, on growth performance, health, and carcass outcomes in finishing steers in North America. J Anim Sci. 2016;94(4):1662-1676.
Rumensin and Tylan are registered trademarks of Eli Lilly and Company, its subsidiaries or affiliates.